The association of clopidogrel and 2-oxo-clopidogrel plasma levels and the 40 months clinical outcome after primary PCI
Conclusion Clopidogrel dose-adjusted plasma concentration in STEMI patients, as well as multivessel coronary artery disease, showed significance in predicting an unfavorable composite clinical outcome after 40-month follow-up.
Source: International Journal of Clinical Pharmacy - Category: Drugs & Pharmacology Source Type: research
More News: Aspirin | Cardiology | Cardiovascular | Clopidogrel | Fentanyl | Heart | Heart Attack | Heart Failure | Ischemic Stroke | Pain | Plavix | Serbia Health | Stroke | Study | Teaching | Teaching Hospitals | Universities & Medical Training